BAPTIST HEALTH MEDICAL CENTER- NLR
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $49K
- Transactions
- 29
- Companies
- 17
- Average per transaction
- $1,701
Who reported the payments
| Boston Scientific | $9,000 |
| AstraZeneca | $6,000 |
| Linvatec Corporation | $5,896 |
| UCB, Inc. | $5,000 |
| Medline Industries LP | $3,619 |
| Kedrion Biopharma, Inc. | $3,450 |
| Novo Nordisk | $3,050 |
| Vertex | $3,000 |
| AbbVie | $3,000 |
| Neurelis, Inc. | $3,000 |
| Aimmune Therapeutics, Inc. | $1,500 |
| Boehringer Ingelheim | $1,500 |
| Organon | $700 |
| Abbott | $284 |
| Stryker | $254 |
| Barco, Inc. | $42 |
| SCA Pharmaceuticals, LLC | $23 |